Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February


Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company's management team will participate in fireside chats at the following investor conferences in February:

To access the webcast links, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. Replays will also be available at the same location for at least 30 days.

About Exelixis

Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.

Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.


These press releases may also interest you

at 12:40
Global AI Text Generator Research Report 2024-2029: Multilingual/Multimodal Text Generation, Personal Assistants and Chatbots, and Rising Demand for Cost-effective and Quality Content - ResearchAndMarkets.com
The "Global AI Text Generator Market: Analysis By Component, By Application, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global AI text...

at 12:30
Lithium Miners Strategize for Long-Term Gains as Market Recovers
USA News Group ? Despite what appears to be a supply glut currently in the global lithium market, already there are signs of a lithium rebound on the horizon. According to Statista, global lithium demand is projected to grow through next year, while...

at 12:25
Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com
The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology...

at 12:15
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer...

at 12:10
Ververica Achieves ISO 27001 Certification, Bolstering Data Security
Ververica, a comprehensive streaming data platform provider, announces the achievement of ISO 27001 certification, a significant milestone in its commitment to data security and governance. This certification is internationally recognized as the gold...

at 12:00
Fertram Sigurjonsson, Founder and CEO of Medical-Fish-Skin Company Kerecis, Receives the EWMA President's Wound Care Entrepreneur of the Year Award
The European Wound Management Association (EWMA) presented Fertram Sigurjonsson, founder and CEO of the medical-fish-skin company Kerecis, with the President's Wound Care Entrepreneur of the Year Award. The award was announced at the annual EWMA...

More news about Science and technology...


News published on and distributed by: